Literature DB >> 23975392

Italian guidelines on thrombolysis indications in ischaemic stroke have been revised after IST 3 trial and Cochrane Review: PROS.

Stefano Ricci1, Silvia Cenciarelli, Tatiana Mazzoli.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23975392     DOI: 10.1007/s11739-013-0987-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  10 in total

1.  rt-PA for ischaemic stroke: what will the next question be?

Authors:  Didier Leys; Charlotte Cordonnier
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

Review 2.  Statistical analysis of the primary outcome in acute stroke trials.

Authors:  Philip M W Bath; Kennedy R Lees; Peter D Schellinger; Hernan Altman; Martin Bland; Cheryl Hogg; George Howard; Jeffrey L Saver
Journal:  Stroke       Date:  2012-03-15       Impact factor: 7.914

3.  Can we extend thrombolysis indications for acute ischaemic stroke? The IST-3 study.

Authors:  Marta Del Medico; Antonella Bonura
Journal:  Intern Emerg Med       Date:  2013-03-01       Impact factor: 3.397

4.  Reliability of the activities of daily living scale and its use in telephone interview.

Authors:  D Shinar; C R Gross; K S Bronstein; E E Licata-Gehr; D T Eden; A R Cabrera; I G Fishman; A A Roth; J A Barwick; S C Kunitz
Journal:  Arch Phys Med Rehabil       Date:  1987-10       Impact factor: 3.966

5.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 6.  Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2007-10-04       Impact factor: 7.914

7.  Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial.

Authors:  Peter Sandercock; Richard Lindley; Joanna Wardlaw; Will Whiteley; Gordon Murray
Journal:  Int J Stroke       Date:  2012-04       Impact factor: 5.266

8.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

Review 9.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

10.  Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke.

Authors:  Peter Sandercock; Richard Lindley; Joanna Wardlaw; Martin Dennis; Steff Lewis; Graham Venables; Adam Kobayashi; Anna Czlonkowska; Eivind Berge; Karsten Bruins Slot; Veronica Murray; Andre Peeters; Graeme Hankey; Karl Matz; Michael Brainin; Stefano Ricci; Maria Grazia Celani; Enrico Righetti; Teresa Cantisani; Gord Gubitz; Steve Phillips; Antonio Arauz; Kameshwar Prasad; Manuel Correia; Phillippe Lyrer
Journal:  Trials       Date:  2008-06-17       Impact factor: 2.279

  10 in total
  5 in total

1.  Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-08-29       Impact factor: 6.829

2.  Italian guidelines on thrombolysis indications in ischemic stroke have been revised after the IST-3 trial and Cochrane review.

Authors:  Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2014-07-23       Impact factor: 3.397

3.  Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for stroke.

Authors:  Maurizio Balestrino; Laura Strada; Chiara Bruno; Cinzia Finocchi; Carlo Gandolfo
Journal:  Intern Emerg Med       Date:  2014-06-17       Impact factor: 3.397

4.  Thrombolysis in the elderly: yes but with caution.

Authors:  Simona Sacco; Silvia Ricci; Francesca Pistoia; Antonio Carolei
Journal:  Intern Emerg Med       Date:  2014-06-17       Impact factor: 3.397

5.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.